AmerisourceBergen is looking to buy pharmaceutical packaging and distribution assets using some of the $2bn (€1.4bn) it has accumulated. Strong sales have helped AmerisourceBergen grow its cash reserves by 20 per cent over the past year and the company now plans to spend some of its money. Pharma distribution and packaging services companies are being targeted, and AmerisourceBergen is willing to spend big on the right business. “While we historically have been very comfortable in the $200m to $300m range, we will consider something larger if it made good strategic sense”, said Steven Collis, CEO of AmerisourceBergen, in a conference call with investors.
